Back to Journals » Drug Design, Development and Therapy » Volume 12

Schisandrin B protects against angiotensin II-induced endotheliocyte deficits by targeting Keap1 and activating Nrf2 pathway

Total article views   HTML views PDF downloads Totals
9,834 Dovepress* 9,430+ 746 10,176
PubMed Central* 404 143 547
Totals 9,834 889 10,723
*Since 22 November 2018

View citations on PubMed and Google Scholar